Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459355 · ClinicalTrials.gov registry record · Phase 1
Home Safety Clinical Trial for Alzheimer's Disease
A Phase 1 study of Dementia and Alzheimers Disease, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 1
- Development phase
- 254
- Enrollment target
- 1
- Study location
NCT00459355: Completed Phase 1 study of Dementia and Alzheimers Disease, sponsored by US Department of Veterans Affairs.
NCT00459355 is a Phase 1 study of Dementia and Alzheimers Disease that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 254 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00459355, a Phase 1 study of Dementia and Alzheimers Disease, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 254 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to test the effectiveness of a new multimodal educational intervention to improve home safety for persons with dementia of the Alzheimer's type and their home caregivers.
Primary Outcome
Caregiver Strain was measured by the MBRC Caregiver Strain Index; scores ranged from 0 - 15 with higher scores indicating more strain.
Conditions Studied
Interventions
- BEHAVIORAL Home Safety Toolkit
Study Locations (1)
Massachusetts
- Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA - Bedford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
What the finished NCT00459355 record still lists
NCT00459355 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which Home Safety Toolkit is the first listed.
NCT00459355 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00459355 about?
NCT00459355 is a clinical study titled "Home Safety Clinical Trial for Alzheimer's Disease". The purpose of this study was to test the effectiveness of a new multimodal educational intervention to improve home safety for persons with dementia of the Alzheimer's type and their home caregivers.
What is the current status of trial NCT00459355?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 254 participants. The study started on 2007-07. Estimated completion is 2011-12.
What conditions does trial NCT00459355 study?
This clinical trial studies the following conditions: Dementia, Alzheimers Disease.
What interventions are being tested in trial NCT00459355?
The interventions under investigation include: Home Safety Toolkit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00459355?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00459355 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00459355's enrollment target sits among peer trials
254 80th of 199 higher than 120 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer
RECRUITING · Phase 1
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
RECRUITING · Phase 1
-
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
RECRUITING · Phase 1
-
Sirtuin-NAD Activator in Alzheimer's Disease
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia